Assay platform released to Z'-LYTE of all

FRAMINGHAM (10/23/2003) - The Z'-LYTE assay platform from Invitrogen Corp. is a fluorescence-based biochemical detection technology used to screen for potential inhibitors of protein kinases and phosphatases. Designed for high-throughput screening applications, Z'-LYTE employs the Fluorescence Resonance Energy Transfer (FRET) assay method for quick assay development and consistent results.

Compatible with most automated systems, Z'-LYTE does not require radioactive or antibody-based reagents. Invitrogen offers custom assay development services for increased flexibility.

BLAzing New Trails Invitrogen is also promoting GeneBLAzer Technology research tools, a reporter technology based on the enzyme ß-lactamase. The company acquired the rights to GeneBLAzer from Pan Vera in March.

Vendor: Invitrogen

Product Name: Z'-LYTE

Availability: Now

For more information: www.invitrogen.com

Join the newsletter!

Or

Sign up to gain exclusive access to email subscriptions, event invitations, competitions, giveaways, and much more.

Membership is free, and your security and privacy remain protected. View our privacy policy before signing up.

Error: Please check your email address.

More about InvitrogenTechnology Research

Show Comments
[]